Evolutionary Algorithms for Minimax Problems in Robust Design von Cramer, A.M., Sudhoff, S.D., Zivi, E.L.

Volltext

Evolutionary Optimization of PowerElectronics Based Power Systems von Chan, R.R., Yonggon Lee, Sudhoff, S.D., Zivi, E.L.

Volltext

Metric Optimization-Based Design of Systems Subject to Hostile Disruptions von Cramer, A. M., Sudhoff, S. D., Zivi, E. L.

Volltext

Evolutionary Optimization of Power Electronics Based Power Systems von CHAN, Ricky R, LEE, Yonggon, SUDHOFF, Scott D, ZIVI, Edwin L

Volltext

Start up performance of load-commutated inverter fed synchronous machine drives von Sudhoff, S.D., Zivi, E.L., Collins, T.D.

Volltext

Evolutionary Optimization of Power Electronics Based Power Systems von Chan, R. R., Sudhoff, S. D., Lee, Y., Zivi, E. L.

Volltext

Shipboard electrical system modeling for early-stage design space exploration von Cramer, A. M., Hanling Chen, Zivi, E. L.

Volltext bestellen

Shipboard Controls of the Future von Amy Jr, J. V., Doerry, N. H., McCoy, T. J., Zivi, E. L.

Volltext

Integrated shipboard power and automation control challenge problem von Zivi, E.L.

Volltext bestellen

Shipboard controls of the future. Commentary von AMY, J. V, DOERRY, N. H, MCCOY, T. J, ZIVI, E. L, DAVIS, J. C

Volltext

An optimization approach to estimating stability regions using genetic algorithms von Loop, B.P., Sudhoff, S.D., Zak, S.H., Zivi, E.L.

Volltext

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy von Scher, Howard I, Fizazi, Karim, Saad, Fred, Taplin, Mary-Ellen, Sternberg, Cora N, Miller, Kurt, de Wit, Ronald, Mulders, Peter, Chi, Kim N, Shore, Neal D, Armstrong, Andrew J, Flaig, Thomas W, Fléchon, Aude, Mainwaring, Paul, Fleming, Mark, Hainsworth, John D, Hirmand, Mohammad, Selby, Bryan, Seely, Lynn, de Bono, Johann S

Volltext

Abiraterone and Increased Survival in Metastatic Prostate Cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

Volltext

607O Interim results of a phase I study of SGN-PDL1V (PF-08046054) in patients with PDL1-expressing solid tumors von Oliva, M., Ochsenreither, S., Le Tourneau, C., Champiat, S., Saleh, R., Burkitt, K., Nabell, L., Steeghs, N., Spreafico, A., Minchom, A.R., Patnaik, A., Call, J.A., Fontana, E., Kotecki, N., Garralda, E., Zivi, A., Riess, J.W., Gupta, S., Zhang, R., Gillison, M.

Volltext

Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis von Gillessen, S., Schmid, S., Beltran, H., Almeida, D.V.P., Mehra, N., Lavaud, P., Morales Barrera, R., Pignataro, D., Castro Marcos, E., Conteduca, V., Efstathiou, E., Le, H.M.L., Pezaro, C.V., Suzuki, H., Zivi, A., Klingbiel, D., Omlin, A.G.

Volltext

814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis von Gillessen, S, Schmid, S, Beltran, H, Almeida, D V P, Mehra, N, Lavaud, P, Morales Barrera, R, Pignataro, D, Castro Marcos, E, Conteduca, V, Efstathiou, E, Le, H M L, Pezaro, C V, Suzuki, H, Zivi, A, Klingbiel, D, Omlin, A G

Volltext

30 Weight change analysis in advanced castration resistant prostate cancer (CRPC) patients treated with Abiraterone Acetate (AA) single agent and in combination with steroids von Bianchini, D, Zivi, A, Attard, G, Mezynski, J, Cassidy, A, Sandhu, S, Hunt, J, Sheridan, L, Thompson, E, de Bono, J.S

Volltext

An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome von Olmos, D., Clark, J., Brewer, D., Barwell, L., Attard, G., Reid, A. H., Sandhu, S. K., Zivi, A., Bianchini, D., Babu Oomen, N., Thompson, E., Molife, L. R., Kaye, S. B., Parker, C., Cooper, C., Jones, R. J., De Bono, J. S.

Volltext

Phase II dose escalation study of sorafenib in patients with metastatic renal cell carcinoma (mRCC) who have had prior treatment with VEGFR-TKI antiangiogenic treatment von Mancuso, A. P., Donato De Paola, E., Catalano, A., Calabrò, F., Messina, C., Zivi, A., Cerbone, L., Vigna, L., Caristo, R., Sternberg, C. N.

Volltext

Abiraterone and increased survival in metastatic prostate cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I, COU-AA-301 Investigators, [missing], Rottey, Sylvie

Volltext